PRINCETON, N.J., May 30, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (NASDAQ:PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today announced that David H. Mack, Ph.D., President and Chief Executive Officer and Deepika Jalota, Pharm. D., Chief Development Officer, will participate at the following investor conferences in June. Management will also participate in one-on-one investor meetings. Jefferies Global Healthcare Conference (June 5 – 6, 2024) Format: Fireside ChatDate: Thursday, June 6, 2024 Time: 2:00 – 2:25 PM ET Goldman Sachs 45th Annual Global Healthcare Conference (June 10 – 13, 2024)